企业名称：湖北丰山新材料科技有限公司 许可范围：4-氯甲苯24500吨/年、2-氯甲苯25500吨/年、2,4-二氯甲苯6000吨/年、3,4-二氯甲苯1500吨/ 年、2,6-二氯甲苯7600吨/年，副产盐酸79977吨/年，次氯酸钠溶液7800吨／年。** 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或者重大遗漏，并对其内容 的真实性、准确性和完整性承担法律责任。 江苏丰山集团股份有限公司（以下简称"公司"）于2025年1月9日披露了《关于募投项目建设进展的公 告》（公告编号：2025-004），由公司全资子公司湖北丰山新材料科技有限公司（以下简称"湖北丰 山"）实施的"年产 24,500 吨对氯甲苯等精细化工产品建设项目"于2025年1月进入试生产阶段。目前， 该项目已通过安全设施竣工验收，湖北丰山于近日取得由湖北省应急管理厅颁发的《安全生产许可 证》，现将相关情况公告如下： 一、《安全生产许可证》主要内容 证书编号：（鄂）WH安许证〔2025〕1323号 江苏丰山集团股份有限公司董事会 2026年1月1日 同时，湖北丰山的对氯甲苯产品已作为公司氟乐灵产品的原料投入使用，进一步完善 ...

格隆汇12月31日丨丰山集团(603810.SH)公布，公司于2025年1月9日披露了《关于募投项目建设进展的 公告》(公告编号：2025-004)，由公司全资子公司湖北丰山新材料科技有限公司(以下简称"湖北丰山") 实施的"年产24,500吨对氯甲苯等精细化工产品建设项目"于2025年1月进入试生产阶段。目前，该项目 已通过安全设施竣工验收，湖北丰山于近日取得由湖北省应急管理厅颁发的《安全生产许可证》。 同时，湖北丰山的对氯甲苯产品已作为公司氟乐灵产品的原料投入使用，进一步完善了氟乐灵的产业链 布局，通过提高原料自给率增强了产品竞争力。 本次《安全生产许可证》的取得，标志着湖北丰山"年产24,500吨对氯甲苯等精细化工产品建设项目"迈 入正式生产阶段。这将进一步优化公司的产业布局，构建多元化的产品体系，有助于提升公司的竞争力 和盈利能力，并为未来湖北丰山开发具备高附加值的下游子产品奠定坚实基础。 ...

Core Viewpoint - The solid-state battery sector is experiencing significant activity, with multiple stocks, including Fengshan Group and Xiangtan Electric, hitting the daily limit up, driven by advancements in lithium battery polymer electrolyte research led by a team from Tsinghua University [1][3]. Group 1: Stock Performance - The solid-state battery sector saw a strong performance on September 29, with stocks like Wanrun New Energy leading with a 20% limit up, while Fengshan Group, Xiangtan Electric, and others also reached their daily limit [1]. - Fengshan Group's stock price reached 15.71 CNY per share, with a P/E ratio of 42.82 and a total market capitalization of 2.596 billion CNY [1]. Group 2: Company Developments - Fengshan Group, traditionally focused on the pesticide industry, is accelerating its penetration into the new energy sector, particularly in solid-state batteries, achieving a technological edge [3]. - The subsidiary Fengshan Quannuo New Energy Technology Co., Ltd. is currently focused on the research and development of electrolytes and solid-state materials, with a 50,000-ton battery electrolyte project officially launched [3].

Core Viewpoint - Jiangsu Fengshan Group Co., Ltd. maintains an AA- credit rating with a stable outlook, reflecting its strong product structure and customer quality, despite facing challenges in profitability and industry conditions [4][9]. Company Overview - The company primarily engages in the research, production, and sales of pesticide active ingredients, formulations, and fine chemical intermediates [11]. - The fine chemical segment has entered trial production, enhancing the company's product chain and competitiveness [6][11]. Financial Performance - Total assets as of March 2025 are 27.81 billion, with equity attributable to shareholders at 15.91 billion [4]. - Revenue for 2023 is reported at 3.22 billion, a decline from 10.44 billion in 2022, with a net profit of 0.15 billion, recovering from a loss of 0.42 billion in 2022 [4][5]. - The company’s operating cash flow has been negative, indicating challenges in cash generation [4]. Industry Environment - The pesticide industry is currently at a cyclical low, with a projected slight decline in revenue for 2024, while the net profit is expected to remain a loss of 0.39 billion [6][9]. - The global pesticide market is expected to grow from 790.6 billion in 2024 to 1,185.1 billion by 2031, driven by increasing food demand and pest control needs [14]. Risks and Challenges - The company faces risks related to the commercialization of sodium-ion electrolyte products, which are not progressing as expected, leading to underutilization of production capacity [7][8]. - Environmental and safety production risks are heightened due to stricter regulations in the chemical industry [8][9]. Market Position - The company has a competitive edge in its core pesticide products, with significant market share in active ingredients like Fluorochloromethane and Quinclorac [15][16]. - The sales concentration remains low, with a diverse customer base, reducing dependency on a few clients [19]. Future Outlook - The credit rating agency maintains a stable outlook for the company, anticipating gradual recovery in market demand and pricing for its main products [9][12]. - The company is actively managing inventory and production to align with market conditions, indicating a strategic approach to navigating current challenges [19].